IMAX Q2 Revenue Jumps 12% to $102.8M, Adjusted EPS Hits Record $0.43
IMAX sits 69% above its 52-week low of $24.2 on elevated volume (1.9× avg).
Summary
IMAX reported Q2 2026 revenue of $102.8M, up 12% year-over-year, and record adjusted EPS of $0.43, driven by strong box office performance. The company also disclosed executive stock trading plans and a $13.7M share buyback.
Key Events · Earnings and Guidance · IMAX
-
Q2 Revenue and Earnings Beat
Revenue of $102.8M increased 12% YoY, beating consensus by nearly 10%. Adjusted EPS of $0.43 was a record, more than doubling the prior year's $0.26.
-
Strong Box Office Performance
Global box office of $284.8M in Q2 was up 1% YoY, with Filmed For IMAX titles like 'Supergirl' capturing over 20% of opening weekend domestic box office on just 1% of screens.
-
Restructuring and Impairment Charges
The company recorded $2.3M in restructuring charges, including a $2.0M impairment on a documentary film asset and $0.3M in termination costs related to organizational optimization.
-
Executive Stock Trading Plans
CEO Richard Gelfond adopted a 10b5-1 plan to exercise and sell up to 356,757 shares starting August 18, 2026. CFO Natasha Fernandes adopted a plan to sell up to 30,000 shares starting September 24, 2026.
Analysis · IMAX · Industrial Applications And Services
A standout second quarter saw IMAX deliver revenue of $102.8 million, beating consensus by nearly 10%, while adjusted earnings per share of $0.43 more than doubled the prior year. The strong Hollywood film slate—particularly Filmed For IMAX titles that captured disproportionate box office share—drove the results. Although the quarter included a $2.0 million impairment on a documentary film and a $1.5 million credit loss provision, the underlying operating momentum is clear. Management also disclosed that the CEO and CFO have adopted 10b5-1 trading plans for stock sales, and the company repurchased $13.7 million of its own shares. A post-quarter tax audit notice from the Canada Revenue Agency adds a layer of uncertainty, but the core business is performing at a high level.
At the time of this filing, IMAX was trading at $41.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $24.20 to $45.52. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.